Potential New Neuroblastoma Treatment

 Exciting news posted by St Baldrick's: the long-term study for the biology- and response-based algorithm on the Children's Oncology Group study ANBL0531 for intermediate risk neuroblastoma is complete and the results have been officially published! In the long-term study, a ten year period, the overall survival rate was 95%, with an event-free survival rate of 82%, which is fantastic!

Read the summary here.

Comments

Popular posts from this blog

Viral Therapy

Common Types of Childhood Cancer

Vision Board